GERMANTOWN, Md., May 15 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that Kenneth Carter Ph.D., President and CEO, is scheduled to provide an update on the Company at the Bank of America Health Care Conference 2006. The conference will be held at the Four Seasons Hotel in Las Vegas, NV on May 16-18, 2006. Dr. Carter is scheduled to present on Thursday, May 18th at 12:40 p.m. PDT - 3:40 p.m. EDT. The presentation will be available live via a webcast and can be accessed through the investor page of Avalon Pharmaceuticals' website at: http://www.avalonrx.com/. An archive of the presentation will be available through June 2, 2006. About Avalon Pharmaceuticals, Inc. Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Avalon seeks to discover and develop novel therapeutics through the use of a comprehensive, innovative and proprietary suite of technologies based upon large-scale gene expression analysis which it calls AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is headquartered in Germantown, Maryland. Contacts: Avalon Pharmaceuticals, Inc. Noonan Russo Gary Lessing Wendy Lau (Media) Executive Vice President & CFO Tel: (212) 845-4272 Tel: (301) 556-9900 Fax: (301) 556-9910 Jane Petrino (Investors) Email: Tel: (212) 845-4274 DATASOURCE: Avalon Pharmaceuticals, Inc. CONTACT: Gary Lessing, Executive Vice President & CFO of Avalon Pharmaceuticals, Inc., +1-301-556-9900, Fax: +1-301-556-9910, ; or Media: Wendy Lau, +1-212-845-4272, or Investors: Jane Petrino, +1-212-845-4274, both of Noonan Russo, both for Avalon Pharmaceuticals, Inc. Web site: http://www.avalonrx.com/

Copyright